A carregar...
Vismodegib for periocular basal cell carcinoma: an international multicentre case series
INTRODUCTION: Vismodegib (Erivedge, Genentech) is a first-in-class inhibitor of the hedgehog (Hh) pathway, which is licensed for use in locally advanced basal cell carcinoma (BCC) and metastatic BCC. The National Institute for Health and Care Excellence withdrew recommendation for use of vismodegib...
Na minha lista:
| Publicado no: | Eye (Lond) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784971/ https://ncbi.nlm.nih.gov/pubmed/31996838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-020-0778-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|